FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39109211000001100: Co-careldopa 50mg/200mg modified-release tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1675301000001111 Co-careldopa 50mg/200mg modified-release tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1675321000001116 Co-careldopa 50mg/200mg modified-release tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

10 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-careldopa 50mg/200mg modified-release tablets Is a Co-careldopa true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Has specific active ingredient Carbidopa monohydrate true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Is a Product containing carbidopa and levodopa false Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tabletmodified-release.oral ontology form and route true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets Plays role Antiparkinson therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sinemet CR 50mg/200mg tablets (Organon Pharma (UK) Ltd) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Dowelhurst Ltd) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 30 tablet Has VMP True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Doncaster Pharmaceuticals Ltd) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Caramet 50mg/200mg CR tablets (Teva UK Ltd) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (PI) (Waymade Ltd) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Apodespan PR 50mg/200mg tablets (Accord Healthcare Ltd) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Tilolec 200mg/50mg modified-release tablets (Tillomed Laboratories) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Necessity Supplies Ltd) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has VMP True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Lecado 200mg/50mg modified-release tablets (Sandoz Ltd) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Co-careldopa 50mg/200mg modified-release tablets 60 tablet Has VMP True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
Sinemet CR 50mg/200mg tablets (Mawdsley-Brooks & Company Ltd) Is a True Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start